InterWest is proud and privileged to partner with visionary management teams who are shaping the future of Information Technology and Healthcare. The companies they have started are vital parts of the portfolio of industry-leading startups that InterWest has helped over the last four decades.
Gynesonics is developing a minimally-invasive, uterine-sparing treatment for fibroid tumors. It is an ultrasound-guided needle ablation device designed for in-office use by the gynecologist.